Lifeline Scientific, Inc RESULTS OF SPECIAL MEETING (9227L)

TIDMLSIC

RNS Number : 9227L

Lifeline Scientific, Inc

06 October 2016

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Lifeline Scientific, Inc.

("LSI" or the "Company")

RESULTS OF SPECIAL MEETING

Lifeline Scientific, Inc. (AIM: LSIC), a leading international provider of clinical products and services in the field of transplantation, announces that at the special meeting of LSI's stockholders held today at 9.00 a.m. local time (US CDT) all resolutions were duly passed and approved. This included resolutions to:

1. adopt the agreement and plan of merger entered into with Shanghai Genext Medical Technology Co., Ltd. and certain of its affiliates (the "Merger Agreement" and the transaction provided for therein, the "Merger"); and

2. approve the cancellation of the admission of LSI's common stock to trading on the AIM market of the London Stock Exchange plc ("AIM") conditional on closing of the Merger (the "Cancellation").

The closing of the Merger is still subject to regulatory review and certain other customary closing conditions as provided for in the Merger Agreement. At least twenty business days prior to the effective time of the Merger, the Company intends to make an application to the London Stock Exchange plc for the Cancellation to take effect from 7.00 a.m. (UK time) on the next business day after the date of the effective time of the Merger. It is currently expected that closing will occur no later than 9 December 2016 (subject to extension under certain circumstances).

LSI will announce further details of the Cancellation timetable in due course. It is expected that the last day of dealing in LSI's common stock prior to their cancellation from trading on AIM and the last day for registration of transfers of LSI's common stock will be the date of the effective time of the Merger. No transfers of LSI's common stock will be registered after that time and date. All of LSI's shares of common stock and the depositary interests representing such common stock held in CREST will be cancelled with effect from the effective time of the Merger.

For further information:

 
 Lifeline Scientific, Inc.                                                www.lifeline-scientific.com 
 David Kravitz, CEO                                                              Tel: [phone] 
 Lisa Kieres, CFO                                                                Tel: [phone] 
 
 Piper Jaffray Ltd. (Financial                                               Tel: [phone] 
  Adviser to LSI) 
 Neil Mackison / Graeme Smethurst 
 
 Panmure Gordon (UK) Limited                                                 Tel: [phone] 
 Freddy Crossley / Duncan Monteith (Corporate 
  Finance) 
 Tom Salvesen (Corporate Broking) 
 
 Walbrook PR Limited                              Tel: [phone] or [e-mail] 
 Paul McManus / Lianne Cawthorne                               Mob: [phone] 
                                                                                              391 303 
 
 

About Lifeline Scientific Inc.

Lifeline Scientific, Inc. is a Chicago-based global medical technology company with regional offices in Brussels and Sao Paulo. The Company's focus is the development of innovative products that improve transplant outcomes and lower the overall costs of transplantation. Its lead product, LifePort Kidney Transporter, is the global market-leading medical device for hypothermic machine preservation of donor kidneys. LifePorts and novel solutions designed for preservation of other organs are in development, with LifePort Liver Transporter next in line for commercial launch. For more information please visit www.lifeline-scientific.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCZQLFBQBFFFBD

(END) Dow Jones Newswires

October 06, 2016 10:18 ET (14:18 GMT)